These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1517921)

  • 1. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
    Pearson E; Bose C; Snidow T; Ransom L; Young T; Bose G; Stiles A
    J Pediatr; 1992 Sep; 121(3):420-7. PubMed ID: 1517921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
    Shenai JP; Kennedy KA; Chytil F; Stahlman MT
    J Pediatr; 1987 Aug; 111(2):269-77. PubMed ID: 3302193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.
    Shenai JP; Rush MG; Stahlman MT; Chytil F
    J Pediatr; 1990 Apr; 116(4):607-14. PubMed ID: 2108233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
    Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
    Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early vs delayed vitamin A supplementation in very-low-birth-weight infants.
    Robbins ST; Fletcher AB
    JPEN J Parenter Enteral Nutr; 1993; 17(3):220-5. PubMed ID: 8505826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants.
    Verma RP; McCulloch KM; Worrell L; Vidyasagar D
    Am J Perinatol; 1996 Oct; 13(7):389-93. PubMed ID: 8960606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
    Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
    J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
    BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin A supplementation on morbidity of low-birth-weight neonates.
    Coutsoudis A; Adhikari M; Pillay K; Kuhn L; Coovadia HM
    S Afr Med J; 2000 Jul; 90(7):730-6. PubMed ID: 10985138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential evaluation of plasma retinol-binding protein response to vitamin A administration in very-low-birth-weight neonates.
    Shenai JP; Rush MG; Parker RA; Chytil F
    Biochem Mol Med; 1995 Feb; 54(1):67-74. PubMed ID: 7551819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin A supplementation in premature neonates with postnatal lung injury. Italian Collaborative Group on Preterm Delivery (ICGPD).
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):362-5. PubMed ID: 8864801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.
    Watts JL; Milner R; Zipursky A; Paes B; Ling E; Gill G; Fletcher B; Rand C
    Eur Respir J; 1991 Feb; 4(2):188-90. PubMed ID: 2044736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vitamin A supplementation in very low birth weight neonates: a randomized controlled trial.
    Basu S; Khanna P; Srivastava R; Kumar A
    Eur J Pediatr; 2019 Aug; 178(8):1255-1265. PubMed ID: 31209560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants.
    Darlow BA; Graham PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000501. PubMed ID: 17943744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
    Gawronski CA; Gawronski KM
    Ann Pharmacother; 2016 Aug; 50(8):680-4. PubMed ID: 27147702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
    Gadhia MM; Cutter GR; Abman SH; Kinsella JP
    J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.